Latest Ratios: P/E Ratio -75.8x · EV/EBITDA 76.1x · ROE -0.4%. (1999–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $9.3B | $7.2B | $8.8B | $10.8B | $10.2B | $12.8B | $8.4B | $8.0B | $4.7B | $5.5B | $3.4B |
| Enterprise Value | $11.1B | $8.9B | $10.8B | $11.7B | $10.8B | $13.2B | $8.6B | $8.2B | $4.7B | $5.6B | $3.5B |
| P/E Ratio → | -75.77 | — | 77.13 | 25.34 | 34.35 | 46.36 | 53.07 | 40.45 | 26.11 | 70.04 | 22.29 |
| P/S Ratio | 2.66 | 2.08 | 2.60 | 3.65 | 4.04 | 5.31 | 4.21 | 3.85 | 2.47 | 3.09 | 2.13 |
| P/B Ratio | 3.71 | 2.85 | 4.83 | 7.65 | 9.02 | 11.83 | 8.59 | 8.51 | 5.12 | 7.36 | 4.91 |
| P/FCF | 38.14 | 514.48 | 64.44 | 44.47 | 70.33 | 67.38 | 35.61 | 56.85 | 24.57 | 49.33 | 36.66 |
| P/OCF | 69.60 | 53.33 | 34.87 | 30.89 | 37.21 | 45.43 | 25.19 | 37.40 | 19.52 | 35.36 | 26.26 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.59 | 3.22 | 3.95 | 4.28 | 5.44 | 4.33 | 3.95 | 2.48 | 3.14 | 2.18 |
| EV / EBITDA | 76.08 | 19.49 | 24.78 | 21.22 | 20.78 | 26.19 | 26.15 | 21.74 | 14.36 | 19.92 | 15.14 |
| EV / EBIT | 46.94 | 108.09 | 42.49 | 20.88 | 25.20 | 32.25 | 35.80 | 27.61 | 17.07 | 23.56 | 16.87 |
| EV / FCF | — | 639.96 | 79.60 | 48.14 | 74.63 | 69.09 | 36.59 | 58.29 | 24.66 | 50.14 | 37.40 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.9% | 45.9% | 49.0% | 51.0% | 51.6% | 50.0% | 47.3% | 48.0% | 47.5% | 46.0% | 46.1% |
| Operating Margin | 6.9% | 6.9% | 7.5% | 14.7% | 17.1% | 17.1% | 12.5% | 14.5% | 13.8% | 12.2% | 11.0% |
| Net Profit Margin | -0.3% | -0.3% | 3.4% | 14.4% | 11.7% | 11.5% | 7.9% | 9.5% | 9.5% | 4.5% | 9.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -0.4% | -0.4% | 7.0% | 33.6% | 26.8% | 26.9% | 16.5% | 21.3% | 21.7% | 10.9% | 21.3% |
| ROA | -0.1% | -0.1% | 2.2% | 10.9% | 8.2% | 8.3% | 5.4% | 8.0% | 8.8% | 4.2% | 8.7% |
| ROIC | 4.4% | 4.4% | 6.1% | 16.1% | 20.5% | 23.7% | 15.9% | 21.8% | 22.3% | 20.1% | 17.6% |
| ROCE | 5.0% | 5.0% | 6.7% | 15.2% | 16.0% | 16.6% | 11.3% | 16.5% | 17.8% | 15.8% | 14.4% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.81 | 0.81 | 1.24 | 0.98 | 1.12 | 1.28 | 0.94 | 0.94 | 0.37 | 0.56 | 0.59 |
| Debt / EBITDA | 4.48 | 4.48 | 5.14 | 2.50 | 2.44 | 2.77 | 2.78 | 2.34 | 1.04 | 1.49 | 1.78 |
| Net Debt / Equity | — | 0.69 | 1.14 | 0.63 | 0.55 | 0.30 | 0.24 | 0.22 | 0.02 | 0.12 | 0.10 |
| Net Debt / EBITDA | 3.82 | 3.82 | 4.72 | 1.62 | 1.20 | 0.65 | 0.70 | 0.54 | 0.06 | 0.33 | 0.30 |
| Debt / FCF | — | 125.47 | 15.16 | 3.66 | 4.30 | 1.71 | 0.98 | 1.44 | 0.10 | 0.82 | 0.74 |
| Interest Coverage | 1.36 | 1.36 | 5.32 | 34.18 | 26.71 | 28.52 | 16.68 | 18.52 | 21.84 | 15.30 | 15.74 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.73 | 1.73 | 1.60 | 1.80 | 2.31 | 2.63 | 2.43 | 2.78 | 2.18 | 2.59 | 2.42 |
| Quick Ratio | 0.87 | 0.87 | 0.77 | 0.99 | 1.44 | 1.88 | 1.56 | 1.89 | 1.33 | 1.66 | 1.58 |
| Cash Ratio | 0.23 | 0.23 | 0.14 | 0.41 | 0.71 | 1.24 | 0.92 | 1.06 | 0.54 | 0.84 | 0.95 |
| Asset Turnover | — | 0.55 | 0.58 | 0.70 | 0.70 | 0.66 | 0.65 | 0.75 | 0.89 | 0.91 | 0.89 |
| Inventory Turnover | 1.70 | 1.70 | 1.61 | 1.50 | 1.53 | 1.70 | 1.51 | 1.87 | 1.95 | 1.96 | 1.97 |
| Days Sales Outstanding | — | 78.17 | 76.03 | 76.56 | 85.86 | 62.93 | 61.58 | 63.79 | 68.78 | 66.00 | 55.25 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% | 0.2% | 0.3% | 0.3% | 0.5% | 0.5% | 0.8% |
| Payout Ratio | — | — | 26.7% | 6.9% | 10.0% | 8.7% | 15.6% | 12.7% | 14.0% | 32.3% | 16.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 1.3% | 3.9% | 2.9% | 2.2% | 1.9% | 2.5% | 3.8% | 1.4% | 4.5% |
| FCF Yield | 2.6% | 0.2% | 1.6% | 2.2% | 1.4% | 1.5% | 2.8% | 1.8% | 4.1% | 2.0% | 2.7% |
| Buyback Yield | 0.1% | 0.1% | 0.0% | 1.4% | 2.6% | 1.2% | 1.5% | 1.8% | 0.0% | 2.8% | 4.7% |
| Total Shareholder Yield | 0.4% | 0.5% | 0.3% | 1.7% | 2.9% | 1.4% | 1.8% | 2.1% | 0.5% | 3.3% | 5.4% |
| Shares Outstanding | — | $152M | $150M | $147M | $149M | $153M | $155M | $157M | $157M | $159M | $162M |
Includes 30+ ratios · 27 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BRKR stock.
Bruker Corporation's current P/E ratio is -75.8x. The historical average is 38.5x.
Bruker Corporation's current EV/EBITDA is 76.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 25.0x.
Bruker Corporation's return on equity (ROE) is -0.4%. The historical average is 12.3%.
Based on historical data, Bruker Corporation is trading at a P/E of -75.8x. Compare with industry peers and growth rates for a complete picture.
Bruker Corporation's current dividend yield is 0.24%.
Bruker Corporation has 45.9% gross margin and 6.9% operating margin.
Bruker Corporation's Debt/EBITDA ratio is 4.5x, indicating high leverage. A ratio above 4x may signal elevated financial risk.
Key Metrics
Top Statement Risk
Negative earnings persistence
Metrics are mathematically derived from official filings.
Earnings Multiples Distorted by Losses
Based on reported figures, Bruker's trailing P/E of -408.73 is not meaningful given negative earnings, so the forward P/E of 28.90 and EV/EBITDA of 24.28 versus 16.84 forward are the more useful anchors for judging how the market is pricing recovery.
The gap between trailing EV/EBITDA of 24.28 and forward EV/EBITDA of 16.84 implies the market expects EBITDA to expand meaningfully, which is a sizeable assumption given revenue growth has slowed to roughly 2.1% year over year. Relative to peers, Bruker's forward multiple sits below Waters at 42.53 trailing P/E and 31.95 EV/EBITDA, consistent with a complexity discount, but it remains elevated for a business with negative net margins. Investors should monitor whether operating margin recovery from the recent -10.4% quarter translates into the earnings the forward multiple implicitly assumes.
Operating Gains Not Reaching Bottom Line
As reported in the quarterly income data, Bruker's operating margin fell from 11.4% in Q4 2025 to -10.4% in Q3 2026 while gross margin held near 49%, indicating the pressure sits below gross profit.
Stable gross margins against a sharp operating margin decline suggest that SG&A and R&D intensity, not product pricing, drove the deterioration. Net margin of -12.8% in the latest quarter, wider than the operating loss, points to non-operating drags such as interest or integration costs that the ratio set alone cannot isolate. Operating margin should be read as the cleaner signal of earning power until the one-time components are disclosed.
Deleveraging Constrained by Thin Coverage
Based on reported figures, Debt/Equity has fallen from 1.31 in Q3 2024 to 0.73 in Q3 2026, but EBITDA-based leverage of 16.18 in Q1 2026 and interest coverage of 2.49 show limited headroom.
The improvement in Debt/Equity reflects a rebuilt equity base as much as debt repayment, so the ratio may overstate the pace of genuine risk reduction. Interest coverage compressed to 2.49 in Q1 2026 from above 5x through 2024, and the latest quarters lack reported coverage, which warrants caution. Refinancing exposure and the sensitivity of debt service to rate conditions remain the key items to monitor.
Current Ratio Masks Thin Cash Cushion
According to recent filings, Bruker's current ratio of 1.84 and quick ratio of 0.90 look adequate, yet cash of $119.7M against $1.7B in total debt leaves a narrow buffer against operating shocks.
A quick ratio near 0.90 indicates the company depends on receivables and inventory conversion rather than cash to meet current obligations, which matters given DSO of 76 days and DIO of 230 days. Under a severe stress scenario, slower collections or inventory build could pressure liquidity faster than the current ratio suggests. The decline in cash from $293.1M a year earlier warrants monitoring alongside the working capital trajectory.
Misapplied Ratio: Current Ratio Overstates Safety
The current ratio is most commonly misapplied to Bruker because its large inventory and project-based BEST segment inflate current assets, overstating the company's ability to meet obligations without asset liquidation.
Inventory days of roughly 230 mean a large share of current assets is tied up in slow-moving systems and components, which the current ratio treats as liquid. A more informative substitute is the quick ratio combined with cash conversion cycle, which at 263 days highlights the working capital drag. Analysts should adjust for lumpy revenue recognition on installed systems before relying on the headline current ratio.